Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis
Open Access
- 13 June 2025
- journal article
- research article
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 13 (8) , 685-698
Abstract
No abstract availableKeywords
Funding Information
- University of Oxford
- NIHR Oxford Biomedical Research Centre
- Cancer Research UK
This publication has 58 references indexed in Scilit:
- The impact of continuity correction methods in Cochrane reviews with single‐zero trials with rare events: A meta‐epidemiological studyResearch Synthesis Methods, 2024
- Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International WorkshopJournal of Bone and Mineral Research, 2020
- Impact of “Tailored” Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1World Journal of Surgery, 2017
- Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1World Journal of Surgery, 2016
- Long‐Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?World Journal of Surgery, 2015
- Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidismBritish Journal of Surgery, 2010
- Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 PatientsWorld Journal of Surgery, 2009
- Is Surgery Beneficial for MEN1 Patients with Small (≤2 cm), Nonfunctioning Pancreaticoduodenal Endocrine Tumor? An Analysis of 65 Patients from the GTEWorld Journal of Surgery, 2006
- Subtotal Parathyroidectomy as an Adequate Treatment for Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1Archives of Surgery, 2006
- Surgical Treatment of Hyperparathyroidism in Patients With Multiple Endocrine Neoplasia Type 1Archives of Surgery, 2005